Discovery of organosulfur-based selective HDAC8 inhibitors with anti-neuroblastoma activity
European Journal of Pharmaceutical Sciences · 2024
DOI: 10.1016/j.ejps.2024.106921 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutical Sciences, 2024. Verfasst von Hyewon Cho und 14 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Sookmyung Women's University, Cheongpa-ro 47-gil 100, Yongsan-gu, Seoul, 04310, Republic of Korea. Hauptthemen laut MEDLINE: Histone Deacetylases, Histone Deacetylase Inhibitors, Neuroblastoma, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Trade, Industry and Energy, Ministry of Health and Welfare, Commercializations Promotion Agency for R&D Outcomes.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Sookmyung Women's University, Cheongpa-ro 47-gil 100, Yongsan-gu, Seoul, 04310, Republic of Korea.
- New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDI hub), Daegu, Republic of Korea.
- Preclincial Research Center (PRC), Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDI hub), Daegu, Republic of Korea.
- College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, 21983, Republic of Korea.
- EONE-DIAGNOMICS New drug R&D Center, 708 MCC B Building, 1071 Anyangcheon-ro, Yangcheon-gu, Seoul, Republic of Korea.
- Laboratory Animal Resource and Research Center, Korea Research Institute of Bioscience and Biotechnology, 30 Yeongudanjiro, Ochang, Cheongwon, Cheongju, 28116, Republic of Korea.
Förderung
- Ministry of Trade, Industry and Energy
- Ministry of Health and Welfare
- Commercializations Promotion Agency for R&D Outcomes
- Korea Drug Development Fund
- National Research Foundation of Korea
Zitieren
APA
Cho, H., Lee, E., Kim, J., Shin, S., Kim, Y. J., Lee, H., Yu, J. H., Jeon, Y. H., Lee, S. W., Lee, S. Y., Park, K. W., Kang, J. S., Kwon, S. H., Kim, Y., & Jeon, R. (2024). Discovery of organosulfur-based selective HDAC8 inhibitors with anti-neuroblastoma activity. European Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.ejps.2024.106921
Vancouver
Cho H, Lee E, Kim J, Shin S, Kim YJ, Lee H, et al. Discovery of organosulfur-based selective HDAC8 inhibitors with anti-neuroblastoma activity. European Journal of Pharmaceutical Sciences. 2024. doi:10.1016/j.ejps.2024.106921
BibTeX
@article{Cho2024,
author = {Cho, Hyewon and Lee, Eun and Kim, Jisoo and Shin, Soojeong and Kim, Yoon-Jung and Lee, Heejin and Yu, Ji Hoon and Jeon, Yong Hyun and Lee, Sang Wu and Lee, So Young and Park, Ki Whan and Kang, Jong Soon and Kwon, So Hee and Kim, Yonjung and Jeon, Raok},
title = {Discovery of organosulfur-based selective HDAC8 inhibitors with anti-neuroblastoma activity},
journal = {European Journal of Pharmaceutical Sciences},
year = {2024},
doi = {10.1016/j.ejps.2024.106921}
}
EUVIMED